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Viral immediate-early (IE) genes are the first class of viral genes expressed during primary infection or reactivation from
latency. They usually encode regulatory proteins that play crucial roles in viral life cycle. In a previous study, four regions in
the KSHV genome were found to be actively transcribed in the immediate-early stage of viral reactivation in primary effusion
lymphoma cells. Three immediate-early transcripts were characterized in these regions, as follows: mRNAs for ORF50
(KIE-1), ORF-45 (KIE-2), and ORF K4.2 (KIE-3) (F. X. Zhu, T. Cusano, and Y. Yuan, 1999, J. Virol. 73, 5556–5567). In the present
study, we further analyzed the expression of genes in these IE regions in BC-1 and BCBL-1 cells. One of the immediate-early
regions (KIE-1) that encompasses ORF50 and other genes was intensively studied to establish a detailed transcription map
and expression patterns of genes in this region. This study led to identification of several novel IE transcripts in this region.
They include a 2.6-kb mRNA which encodes ORF48/ORF29b, a family of transcripts that are complementary to ORF50 mRNA
and a novel K8 IE mRNA of 1.5 kb. Together with the IE mRNA for ORF50 which was identified previously, four immediate-early
genes have been mapped to KIE-1 region. Therefore, we would designate KIE-1 the major immediate-early region of KSHV.INTRODUCTION
Kaposi’s sarcoma-associated herpesvirus (KSHV),
also referred to as human herpesvirus-8 (HHV-8), is a
newly identified gammaherpesvirus, belonging to Rhadi-
novirus genus (Chang et al., 1994; Moore et al., 1996a).
Epidemiologic studies suggest that this virus is an etio-
logic agent of Kaposi’s sarcoma (KS) (Ambroziak et al.,
1995). KSHV is also associated with primary effusion
lymphoma (PEL) (Cesarman et al., 1995) and multicentric
Castleman’s diseases (MCD) (Soulier et al., 1995). KSHV
has been shown able to transform human endothelial
cells (ECs) efficiently. Infection of primary human endo-
thelial cells by purified KSHV causes long-term prolifer-
ation and survival of these cells which are associated
with the acquisition of telomerase activity and anchor-
age-independent growth (Flore et al., 1998). Therefore,
KSHV is a human tumor virus.
As a gammaherpesvirus, KSHV establishes latent in-
fection in lymphoid cells. In latently infected cells that
contain a limited number of the viral genomes, no infec-
tious virus is produced. Only a limited number of viral
genes are expressed during latency and referred to as
latent genes. Five KSHV latent genes were identified,
1 To whom correspondence and reprint requests should be ad-
dressed at Department of Microbiology, School of Dental Medicine,301and they encode v-cyclin, latency-associated nuclear an-
tigen (LANA), v-FLIP, kaposin, and vIRF-2 (LANA-2) (Ditt-
mer et al., 1998; Rainbow et al., 1997; Kedes et al., 1997;
Muralidhar et al., 1998; Sadler et al., 1999; Burysek and
Pitha, 2001). When latency is disrupted, KSHV can switch
to a lytic life cycle (Renne et al., 1996; Miller et al., 1997).
In the lytic phase, the virus expresses its lytic genes in a
temporal and sequential order. A few viral genes are
expressed independently of de novo protein synthesis
and are classified as immediate-early genes. Early
genes are expressed slightly later, and their expression
is not affected by inhibition of viral DNA replication. Late
genes are expressed after viral DNA synthesis, and their
expression is, in general, blocked in the presence of
inhibition of viral DNA synthesis.
Several lines of evidence suggested that the lytic life
cycle of KSHV appears to be important in KSHV patho-
genicity. First, KS is an endothelial neoplasm and latent
KSHV infection is established in lymphocytes well before
the onset of KSHV (Moore et al., 1996b). Therefore, re-
activation of KSHV from a latently infected lymphoid
reservoir seems a necessary antecedent step in KS
development. Second, the viral load in peripheral blood
mononuclear cells increases with progression to KS
(Ambroziak et al., 1995; Whitby et al., 1995). Third, treat-
ment of KS patients or AIDS patients at risk for KS with
antiherpesviral drugs, such as Foscarnet and ganciclovir,In addition, we showed that transcription of K8 gene is con
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KS development (Morfeldt and Torssander, 1994; Martin
et al., 1999). The last, several cytokine-like proteins and
potential transforming proteins are encoded in the KSHV
genome and have been proposed to play important roles
in KS development. Most of them are expressed mainly
after the virus switches to a lytic cycle in PEL cells. Taken
together, these observations suggest that reactivation of
latent KSHV to lytic life cycle is an event not only impor-
tant for viral propagation, but also crucial for viral patho-
genicity.
Reactivation of herpesviruses is initiated and con-
trolled by a small number of regulatory proteins encoded
by viral immediate-early (IE) genes. IE genes are the first
class of the viral genes expressed during primary infec-
tion or reactivation. As their transcription does not re-
quire prior viral protein synthesis, this class of genes is
experimentally defined by their transcription following
primary infection or reactivation in the presence of inhi-
bition of protein synthesis. We have been interested in
KSHV reactivation and working on identification and
characterization of KSHV immediate-early genes. In a
previous study, we selectively induced the transcription
of KSHV immediate-early genes by stimulating BC-1 cells
with sodium butyrate in the presence of cycloheximide.
Then the induced KSHV mRNA sequences were isolated
using a gene expression screen method. This study led
to identification of several immediate-early transcripts
originating from four regions of the viral genome in PEL
cells. These regions were designated as KIE-1, -2, -3, and
-4 (Zhu et al., 1999). In KIE-1 region, a 3.6-kb mRNA was
characterized through isolating and sequencing its full-
length cDNA and found to encode three putative open
reading frames, namely ORF50, K8, and K8.2. A 1.7-kb
mRNA encoding ORF45 and a 2.0-kb mRNA encoding
ORF K4.2 was identified in KIE-2 and -3, respectively.
Among these IE transcripts, ORF50 encodes a transac-
tivator (Rta) which is able to upregulate viral lytic genes
and sufficient to disrupt viral latency in B cells (Sun et al.,
1998; Lukac et al., 1998). ORF45 was recently found to
inhibit virus-mediated interferon- and - induction by
blocking the phosphorylation and nuclear translocation
of cellular interferon regulatory factor-7 (IRF-7) (Zhu et al.,
2002).
In the present study, we further analyzed the expres-
sion of immediate-early genes of KSHV. A major IE region
(KIE-1) that encompasses ORF50 and other genes was
intensively studied to establish a detailed transcription
map of this region. The structure and expression pattern
of each IE transcript in this region was investigated. We
identified two novel immediate-early transcripts, namely
ORF48/29b and ORF50 antisense RNAs. We also showed
that transcription of ORF K8 gene is controlled by two
promoters, yielding two transcripts, an immediate-early
mRNA of 1.5 kb and a delayed-early mRNA of 1.3 kb.
RESULTS
Transcription mapping of two immediate-early regions
in the KSHV genome
Among the four regions in the KSHV genome that were
found to be actively transcribed in the immediate-early
stage of viral reactivation, immediate-early mRNAs were
characterized in three of these regions. They are mRNAs
for ORF50 (KIE-1), ORF45 (KIE-2), and ORF K4.2 (KIE-3)
(Zhu et al., 1999). However, mRNA(s) originating from the
fourth IE locus (KIE-4) which is located approximately
between nucleotides 49,000 and 50,000 in the viral ge-
nome was not characterized (nucleotide numbers are
according to Russo et al., 1996). In addition, Northern
analyses showed that multiple transcripts are expressed
from KIE-1 locus in both directions, but only ORF50 mR-
NAs of 3.6–3.8 were characterized in this region (Zhu et
al., 1999). To continue characterizing immediate-early
transcripts of KSHV, we systematically surveyed gene
transcription in KIE-1 and KIE-4 regions. A series of
single-stranded cDNA probes were prepared to scan
these two regions for transcripts in both orientations.
Positions and orientations of these probes are shown in
Fig. 1. These probes were used to probe Northern blots
containing poly(A) RNA prepared from BC-1 cells that
had been induced with sodium butyrate for 4 and 20 h in
the absence or presence of cycloheximide (50 g/ml), as
well as from BCBL-1 cells treated with TPA (20 ng/ml) for
4 and 20 h. Cycloheximide at 50 g/ml was shown to
block cell protein synthesis within 30 min as indicated by
very low percentage (5%) of [35S]methionine incorpora-
tion by treated cells (Zhu et al., 1999). Cycloheximide was
added 4 h prior to induction. Northern analysis of these
mRNAs detected several transcripts in these two regions
in both BC-1 and BCBL-1 cells (Fig. 2). These transcripts
were classified on the basis of their transcription kinetics
and are listed in Table 1. In KIE-4 region, probe 1 de-
tected a 2.6-kb leftward mRNA in sodium butyrate in-
duced BC-1 cells and TPA-stimulated BCBL-1 cells. The
transcription of this mRNA in BC-1 cells can be induced
regardless of the presence of cycloheximide (50 g/ml)
(Fig. 2A). This mRNA cannot be detected in BCBL-1 cells
in the presence of cycloheximide at 50 g/ml because
BCBL-1 cells are hypersensitive to the toxicity of cyclo-
heximide as previously reported by us and others (Zhu et
al., 1999; Lukac et al., 1999). In the KIE-1 region, besides
the rightward ORF50 mRNAs, there were a number of
leftward transcripts that were transcribed in the IE stage.
They include a 2.6-kb leftward mRNA that encompasses
ORF48 (Fig. 2B) and a family of transcripts (7.4, 3.0, and
1.2 kb) that are complementary to ORF50 mRNA (Fig. 2D).
The presence of cycloheximide (50 g/ml) had little ef-
fect on the transcription of the 2.6-kb mRNA. The 7.4-,
3.0-, and 1.2-kb transcripts can be detected, but in re-
duced levels, in BC-1 cells that were treated with cyclo-
heximide.
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Probe 7 was designed to detect transcripts coding for
ORF K8. Besides the immediate-early ORF50/K8 bicis-
tronic mRNA (3.6 kb) and delayed-early K8 mRNA (1.3 kb)
that had been reported previously (Lin et al., 1999; Zhu et
al., 1999), a 1.5-kb transcript was detected in BC-1 cells at
4 h postinduction and the transcription of this RNA was
not inhibited by the treatment of cycloheximide (Fig. 2F).
Therefore, this mRNA is an immediate-early transcript.
The transcription of two immediate-early mRNAs (3.6-kb
ORF50/K8 and 1.5-kb K8 mRNAs) was found to be tightly
controlled in the latent stage in BC-1 cells. In contrast, a
considerable level of 1.3-kb K8 mRNA was detected in
the latent stage (before induction) (Fig. 2F).
Several delayed-early and late transcripts were
mapped in these two regions. A leftward ORF29 mRNA of
2.1 kb was detected by probe 1 but its transcription was
inhibited in the presence of cycloheximide (Fig. 2A and
Table 1). A leftward ORF49 mRNA of 1.1 kb was detected
in TPA-induced BCBL-1, but not in sodium butyrate stim-
ulated BC-1 cells (Fig. 2C). Probe 6 detected a 0.8-kb
mRNA in BCBL-1 and BC-1 cells (Fig. 2E). This mRNA
was described previously by others and known to en-
code a glycoprotein K8.1 (Chandran et al., 1998; Raab et
al., 1998; Li et al., 1999).
The kinetics of expression of the genes in these two
regions were analyzed by determining the steady-state
levels of these mRNAs in butyrate-induced BC-1 cells at
intervals from 2 to 24 h postinduction. This experiment
revealed that the ORF50 mRNA (3.6–3.8 kb), the 1.5-kb K8
mRNA, the 2.6-kb mRNA(s), and ORF50 antisense RNAs
can be readily detected in 2 h of sodium butyrate treat-
ment, while expression of the mRNAs for ORF29, ORF49,
K8 (1.3 kb), and K8.1 were only detectable at or after 8 h
postinduction (Fig. 2). The transcription of 1.3-kb K8 mR-
NAs was abolished in the presence of cycloheximide,
but was not affected by the treatment with phosphono-
acetic acid (PAA), a herpesviral DNA polymerase inhibi-
tor. Thus, this mRNA is classified as a delayed-early
transcript. The transcription of ORF29 and K8.1 were
inhibited by both cycloheximide and PAA, classified as
late transcripts.
Characterization of 2.6-kb IE transcript
Among the IE transcripts in these two regions, the
2.6-kb mRNA(s) and the transcripts complementary to
ORF50 mRNA were not characterized. To characterize
these IE transcripts, we constructed a cDNA library with
FIG. 1. Mapping of transcripts from the KSHV major immediate-early region. The upper portion of the figure illustrates the location, orientation, and
splicing patterns of major transcripts from KIE-1 and KIE-4 regions. The lower portion shows the positions and orientations of single-stranded DNA
probes that were used in the transcription mapping study.
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FIG. 2. Northern analysis of transcripts in KSHV major immediate-early region. Poly(A) RNAs were isolated from BC-1 cells that had been treated
with sodium butyrate for 4 or 20 h in the absence or presence of cycloheximide and from BCBL-1 cells that had been induced with TPA as indicated
above each lane. These RNAs were separated on a 1.0% agarose-formaldehyde gel and transferred onto nytran membranes. The membranes were
probed with 32P-labeled single-stranded DNA probes that were prepared using asymmetric PCR as described under Materials and Methods. The
probes used for hybridization are indicated in the bottom of each panel, they are probes 1 (A), 2 (B), 3 (C), 4 (D), 6 (E), 7 (F), 8 (G) and 11 (H). The
positions and orientations of these probes are shown in Fig. 1 and Table 1. The right panels are the kinetics of the expression of KSHV immediate-early
mRNAs following an induction of viral reactivation in BC-1 cells. Cells were treated with sodium butyrate for 0, 2, 4, 6, 8, 12, 24, and 48 h. The mRNAs
from cells that were induced with sodium butyrate for 4 h in the presence of cycloheximide (50 g/ml) and cells that were induced for 20 h in the
presence of PAA (0.4 mM) were also included. Molecular marker: 0.24- to 9.5-kb RNA ladder.
mRNA prepared from BC-1 cells which had been stimu-
lated with sodium butyrate for 4 h. This library was
screened with two radioactively labeled cDNA frag-
ments, probes 1 and 3 (see Fig. 1), aiming at obtaining
cDNA clones for the IE mRNA originating from KIE-4
region and the transcripts complementary to ORF50
FIG. 2—Continued
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FIG. 2—Continued
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mRNA. In the screen of the library with probe 1, two
independent clones with inserts of 2.0 and 1.5 kb were
isolated and sequenced. These two clones are termi-
nated 20 and 17 nucleotides downstream of a consensus
AAUAAA polyadenylation signal (nucleotides 49,366 to
49,361), respectively, followed by a poly(A) tail. The 5
FIG. 2—Continued
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ends of these clones are varied and located at nucleo-
tides 70,947 and 70,516, respectively.
One of the cDNA clones was used to prepare single-
stranded 32P-labeled probe using asymmetric PCR for a
Northern analysis of mRNA prepared from uninduced
and induced BC-1 and BCBL-1 cells. The Northern anal-
ysis detected a 2.6-kb mRNA in both sodium butyrate
induced BC-1 and TPA-treated BCBL-1 cells regardless
of the presence of cycloheximide, confirming that the
cDNAs we isolated were indeed for the 2.6-kb IE mRNA
as detected with probes 1 and 2 in KIE-1 and KIE-4
regions (data not shown; the Northern pattern is similar
to that in Fig. 2A).
Since the inserts of these two cDNA clones were only
2.0 and 1.5 kb in length, it appeared that none of them
contains full-length cDNA of the 2.6-kb mRNA and the 5
sequences of the mRNA were missing in both clones. To
determine the 5 end of the 2.6-kb messenger, a rapid
analysis of cDNA ends (RACE) approach was used to
obtain cDNA fragment containing the 5 end of the
mRNA. Two gene-specific primers (GSPs) were designed
(T2.6RACE1: nt 50,022–50,048; T2.6RACE-2: nt 70,883–
70,915) and used in the RACE assay. The 5 RACE reac-
tion generated a PCR product with an estimated size of
600 bp. The PCR products were cloned into pCR2.1
plasmid and four transformants were randomly picked
for sequencing. The result revealed the major transcrip-
tion initial sites at or near the nucleotides 71,402 and
71,403. The transcription initial site of the 2.6-kb mRNA is
only 110 bp apart from that of the ORF50 mRNA that
transcribes rightward. Thus, the IE promoter for 2.6-kb
mRNA could overlap with the promoter controlling
ORF50 gene.
Alignment of the 2.6-kb cDNAs with the KSHV genomic
sequence (Russo et al., 1996) revealed the presence of a
large intervening sequence of nearly 20 kb (nucleotides
70,161 to 50,505) in the gene which specifies the 2.6-kb
mRNA. The intervening sequence is framed by consen-
sus donor and acceptor splicing signals and has been
spliced out in the 2.6-kb mRNA (Fig. 3). The two exons of
the 2.6-kb mRNA encode putative ORF48 and ORF29b,
respectively (Fig. 3). Interestingly, the second exon was
also found in the late ORF29 mRNA of 2.1 kb. A cDNA
clone for the 2.1-kb mRNA was also isolated from a BC-1
cDNA library and was characterized. This mRNA con-
sists of two exons and encodes an open reading frame
TABLE 1









BCBL-1 cells Putative ORFs
Transcription in
cycloheximide
1 49343–50398 2.6 2.6 ORF48, ORF29b 
(Rightward) 2.0 2.0 ORF29 
2 70883–71402 7.4 7.4 /
(Rightward) 4.4 4.4 /
2.6 2.6 ORF48, ORF29b 
3 71640–72298 7.4 7.4 /
(Rightward) 3.0 3.0 
1.3 ORF49
4 73486–74358 7.4 7.4 /
(Rightward) 3.0 3.0 
1.2 1.2 
5 74880–76737 ND ND
(Rightward)
6 76432–75839 4.3 4.3
(Leftward) 2.0 2.0
0.9 0.9 K8.1 
7 75791–74880 4.3 4.3 
(Leftward) 3.6–3.8 3.6–3.8 ORF50, K8 
1.5 1.5 K8 
1.3 1.3 K8 
8 74358–73486 4.3 4.3 
(Leftward) 3.6–3.8 3.6–3.8 ORF50, K8 
9 72614–71640 ND ND
(Leftward)
10 71382–70883 ND ND
(Leftward)
11 50222–49343 5.0 5.0 
(Leftward) 4.5 
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of 687 amino acids (ORF29). A comparison between the
immediate-early 2.6 kb and late 2.1 kb mRNAs in their
structures and splice sites is shown in Fig. 3.
Characterization of the transcripts that are
complementary to ORF50 mRNA
Transcription mapping of KIE-1 region revealed three
leftward transcripts of 7.4, 3.0, and 1.2 kb in both BC-1
and BCBL-1 cells (Fig. 2D). cDNA clones for the 3.0- and
1.2-kb mRNA were obtained. The cDNAs for the 3.0-kb
mRNA were isolated from sodium butyrate induced BC-1
cDNA library with the probe 3 (nucleotides 71,640 to
72,298; see Fig. 1). The cDNA for the 1.2-kb mRNA were
obtained by a PCR-based cDNA procedure followed by
cloning into pCR2.1 vector. Both 3.0- and 1.2-kb mRNAs
initiate at or near the nucleotide 74,518. The 1.2-kb mRNA
terminates 12 to 32 nucleotides downstream of a con-
sensus AAUAAA polyadenylation signal between nucle-
otides 73,522 and 73,517. The 3.0-kb mRNA terminates 11
to 22 nucleotides downstream of the AAUAAA signal
between 71,634 and 71,629. Both 1.2- and 3.0-kb mRNAs
appear to be unspliced transcripts. No large open read-
ing frame was found in either 3.0- or 1.2-kb transcripts.
Thus, it is possible that these ORF50 antisense RNAs do
not encode any peptide but function in RNA level. These
two transcripts were designated T3.0 and T1.2, respec-
tively (Fig. 1).
Characterization of immediate-early and delayed-early
transcripts of ORF K8
The 1.5-kb K8 mRNA is an immediate-early transcript,
while 1.3-kb K8 mRNA is a delayed-early (DE) transcript.
Since the transcription of these two RNAs are under
different transcriptional regulation, we speculated that
the 1.5- and 1.3-kb transcripts differ in their 5 proximal
sequences. To reveal the structural difference between
1.5-kb IE and 1.3-kb DE K8 mRNAs, the 5 RACE was
performed to obtain cDNA containing the 5 proximate
sequences of both mRNAs. Two K8-specific primers
(K8C: nt 75,791–75,777; K8RACE-1: nt 75,136–75,110) were
used in the RACE analysis. The 5 RACE reaction gen-
erated two PCR products with estimated sizes of 330 and
580 bp (Fig. 4A). The PCR products were cloned into
pCR2.1 vector and clones were randomly picked for se-
quencing. Compilation of these sequences revealed two
major potential transcription start sites of K8 gene, one
ranging between nucleotide 74,589 and 74,602, another
at or near 74,845. This result suggested that there are at
least two major transcription start sites for K8 mRNA,
FIG. 3. Genomic organization of the genes for 2.6-kb immediate-early and 2.1-kb late ORF29 mRNAs (A). The splice donor and acceptor sites of
the 2.6- and 2.1-kb mRNAs are compared in (B). The transcription start and stop codons for potential open reading frames in these mRNAs are
indicated.
309IMMEDIATE-EARLY TRANSCRIPTS OF KSHV
presumably corresponding to 1.5-kb IE and 1.3-kb DE
transcripts detected in Northern analysis (Fig. 4B).
The upstream sequences in front of these two tran-
scription initiation sites have been analyzed for promoter
activities. An IE promoter activity and a DE promoter
activity were detected in their upstream sequences, re-
spectively. The detailed information about the analyses
of these two promoters will be published separately
(Wang and Yuan, unpublished observations).
DISCUSSION
Viral immediate-early genes usually encode regulatory
proteins that play essential roles in viral primary infection
and reactivation from latency. Therefore, these genes
always gain extraordinary attention in virological studies.
In a previous study, we identified four loci in the KSHV
genome that are actively transcribed in the immediate-
early stage. Three immediate-early transcripts were
FIG. 4. (A) 5RACE analysis of K8 mRNAs in BC-1 cells at 4 h postinduction with sodium butyrate. The ethidium bromide stained agarose gel shows
two RACE products of 580 and 330 bp. (B) Schematic representation of structures of 1.5-kb immediate-early and 1.3-kb delayed-early K8 mRNAs.
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characterized in these regions: ORF50, ORF45, and K4.2
(Zhu et al., 1999). In the present study, we continue to
characterize KSHV transcripts in these regions. We care-
fully mapped two KSHV immediate-early regions, KIE-1
and KIE-4. This study led to identification of several novel
immediate-early transcripts, including a 2.6-kb mRNA
which encodes ORF48/ORF29b and a family of tran-
scripts that are complementary to ORF50 mRNA. In ad-
dition, we found that K8 gene, which encodes a bZip
protein, expresses two types of transcripts, 1.5-kb imme-
diate-early and 1.3-kb delayed-early mRNAs. These two
mRNAs are transcribed under control of two distinct
promoters.
KIE-1 is a major immediate-early region
The original goal of this study was to characterize
immediate-early transcripts in two immediate-early loci
(KIE-1 and KIE-4) that are 20 kb apart in the KSHV
genome. To our surprise, the 2.6-kb IE mRNA, which was
originally detected in KIE-4 locus, is found to initiate from
KIE-1 region and extend to KIE-4 locus. The transcription
initiation site of 2.6-kb mRNA is only 110 bp apart from
that of ORF50 transcript. In addition, a family of IE
transcripts (T3.0 and T1.2) and a novel K8 IE mRNA of 1.5
kb were identified and mapped in KIE-1 region. Thus,
four IE promoters have been found in KIE-1 region; they
are for ORF50, ORF48/29b (2.6 kb), K8 (1.5 kb), and ORF50
antisense RNAs. Therefore, we would designate KIE-1
locus the major immediate-early region in the KSHV
genome.
The 2.6-kb IE transcript
The gene for the 2.6-kb IE mRNA consists of two exons
that are predicted to encode ORF48 and ORF29b, re-
spectively (Fig. 3). The structure of this gene is interest-
ing in two aspects. First, two exons are separated by a
very large intron (20 kb) in the KSHV genome. Second,
the gene shares the second exon with another viral
gene, namely ORF29. ORF29 also consists of two exons
which are separated by a 4-kb intron harboring two viral
genes on the opposite strand. The ORF29 gene and its
splice arrangement are highly conserved among the
herpesviral family (including three subfamilies, , , and
). KSHV ORF29 is predicted to encode a protein of 687
amino acids. The counterparts of the protein in other
herpesviruses, i.e., UL15 of herpes simplex virus type 1
(HSV-1), are known to involve the cleavage and packag-
ing of viral DNA into capsids (Baines et al., 1994). The
KSHV ORF29 mRNA (2.1 kb) and the 2.6 IE mRNA differ in
their 5 sequences and share a common 3 sequence
from the same exon 2. Unlike 2.1-kb ORF29 mRNA, the
2.6 IE transcript appears to be a bicistronic transcript
encoding ORF48 and a N-terminally truncated ORF29
protein with predicted molecular weight of 32 kDa (des-
ignated ORF29b). Interestingly, the truncated protein was
detected in HSV-1 (also 32 kDa, designated UL15.5)
(Baines et al., 1997; Yu et al., 1997; Yu and Weller, 1998).
The function of HSV UL15.5 is unknown. Whether
ORF29b protein is synthesized from the 2.6-kb KSHV
mRNA has not yet been examined. Further analysis of
expression of ORF48 and ORF29b as well as their func-
tions await the availability of specific antibodies against
KSHV ORF48 and ORF29b. Generation of these antibod-
ies is in progress.
A family of transcripts complementary to ORF50
mRNA
Northern analyses with single-stranded DNA probes
detected multiple, divergent transcripts in the ORF50
locus. The structure of the rightward 3.6- to 3.8-kb mRNA
for ORF50 was described previously (Sun et al., 1998;
Zhu et al., 1999; Lukac et al., 1999). In this article, we
identified and characterized three novel transcripts of 7.4,
3.0, and 1.2 kb that are transcribed from the opposite
strand of ORF50 DNA template. An analysis using the
GCG Frame Program suggested that these transcripts do
not encode any large open reading frame. Although the
possibility that these transcripts encode very small pep-
tide(s) could not be ruled out, it is possible that these
transcripts function at the RNA level. This hypothesis can
be clarified by determining whether these RNAs are
associated with polysomes in cells through a sucrose
gradient analysis. Nevertheless, T1.2 and T3.0 RNAs are
of interest because they serve as antisense RNAs of
ORF50 mRNA. In recent years, several sense–antisense
transcript pairs have been reported in either viruses or
cells. For example, the 8.3-kb latency associate tran-
scripts (LATs) of HSV and its 2.0- and 1.5-kb spliced
products are antisense to immediate-early messengers
ICP-0 and 34.5 and have been proposed to function as
repressor of lytic replication of HSV (Stevens et al., 1987;
Spivack and Fraser, 1987). Unlike LATs, the T1.2 and T3.0
RNA and ORF50 mRNAs were found to be expressed at
the same stage of the viral life cycle. It suggests that
there may be a new mechanism underlying the sense–
antisense RNA pair for gene regulation. An unique anti-
sense mechanism in regulating the stability of the basic
fibroblast growth factor (bFGF) mRNA has been reported
in amphibians, birds, and mammals (Kimelman and
Kirschner, 1989; Borja et al., 1994; Knee et al., 1994). A
transcript is synthesized in the opposite direction of the
bFGF mRNA and overlaps part of the coding sequence of
bFGF. The antisense RNA causes modification of the
bFGF mRNA during maturation of Xenopus oocyte, con-
verting some adenine residues to inosine in the overlap
region (Kimelman and Kirschner, 1989). It is possible that
KSHV ORF50 gene is regulated in a similar positive
fashion by its antisense RNAs.
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ORF K8 gene is expressed in IE and DE phases
under control of two distinct promoters
ORF K8 was previously identified on a delayed-early
transcript of 1.3 kb (Lin et al., 1999). The mRNA is highly
spliced, which generates three splice variants of K8 as a
result of alternative splicing. K8 is the major form, which
codes for a 237 amino acid protein with a basic-leucine
zipper domain near its C-terminus and an acidic domain
near its N-terminus. Such a structure was found in many
transcriptional regulators that compose a large bZip fam-
ily. The two other variants, K8 and K8, encode proteins
sharing the N-terminal portion with K8, but lacking the
C-terminal Zip domain (Lin et al., 1999; Zhu et al., 1999).
K8 protein, especially the  form, displays limited simi-
larity to the ZEBRA protein of Epstein–Barr virus (EBV)
and the c-Jun proto-oncogene product (Lin et al., 1999;
Zhu et al., 1999). The EBV ZEBRA protein is a transcrip-
tional activator which activates the viral lytic gene ex-
pression cascade and initiates the switch of EBV from
latency to lytic life cycle (Miller, 1990). The ZEBRA also
binds to EBV lytic DNA replication origin (Ori-Lyt) and its
binding is essential for viral lytic DNA replication (Fixman
et al., 1995). KSHV K8 is a fascinating protein. Its bZip
structure and homology to EBV ZEBRA protein suggest
that it is a regulatory protein and may involve either
transcription or viral lytic replication. Its complicated and
highly regulated splicing pattern suggests its importance
to viral life cycles. Recently, we found that K8 bZip protein
binds to a DNA sequence within the KSHV lytic DNA
replication origin (Lin and Yuan, 2002). Wu et al. (2001)
reported that K8 is incorporated into KSHV DNA replica-
tion compartments formed with six core KSHV replication
proteins. However, the function of K8 and its role in KSHV
replication have not been understood. In this study, we
found that K8 is expressed in both immediate-early and
delayed-early stages in that the transcription of K8 is
controlled by two different promoters. This result sug-
gested that K8 may have two distinct functions in the two
stages similar to its EBV counterpart, the ZEBRA protein.
MATERIALS AND METHODS
Cell culture
BC-1 (Cesarman et al., 1995) cells were purchased
from the American Type Culture Collection (ATCC) and
grown in RPMI 1640 medium (Gibco-BRL, Gaithersburg,
MD) supplemented with 15% fetal bovine serum (Gibco-
BRL). BCBL-1 (Renne et al., 1996) cells were obtained
from the NIH AIDS Research and Reference Reagent
Program and grown in RPMI 1640 medium supple-
mented with 10% fetal bovine serum. All cultures con-
tained penicillin–streptomycin (50 units/ml) and fungi-
zone (1.25 g/ml amphotericin B and 1.25 g/ml sodium
desoxycholate).
Chemical induction
BC-1 cells were induced with 3 mM of sodium butyrate
(Sigma, St. Louis, MO). BCBL-1 cells were treated with 20
ng/ml of phorbol-12-tetradecanoate-13-acetate (TPA).
When induction was accompanied by inhibition of pro-
tein synthesis, cycloheximide (Sigma) was added in the
culture to 50 g/ml 4 h prior to the induction.
Northern blotting and hybridization
Total RNA was isolated from cells using Trizol reagent
(Gibco-BRL) and poly(A) mRNA was purified using the
PolyAtract mRNA isolation system (Promega, Madison,
WI). The mRNA was separated by electrophoresis in 1%
agarose/6% formaldehyde gel in 20 mMMOPS buffer, pH
7.0. Each lane was loaded with mRNA from 2 107 cells.
The RNA was transferred to a Nytran membrane and
hybridized with a single-stranded 32P-labeled probe. Sin-
gle-stranded DNA probes were prepared using asym-
metric PCR with linearized plasmid templates and spe-
cific oligonucleotide primers, which were either a plas-
mid vector primer (i.e., KS or SK primers in pBluescript) or
a primer specific to an insert sequence. The labeling
reactions were performed in 15 l of reaction solution
(1 Taq polymerase buffer, 16.67 M each dATP, dGTP,
dTTP, 1.67 M dCTP, 5 l [-32P]dCTP (800Ci/mmol, 10
Ci/l, Amersham), 100 ng DNA, 20 pmol primer, and 2.5
units Taq polymerase). The PCR initiated with a denatur-
ing step of 2 min at 94°C, followed by 15 cycles of
sequential steps of 1 min at 94°C, 1 min at 50°C, and 3
min at 74°C. Finally, the reaction was extended for 10 min
at 74°C. RNA loading equivalence was controlled by
probing with -actin cDNA. A measure of 0.24–9.5 kb
RNA ladder (Gibco-BRL) was included in each agarose–
formaldehyde gel and detected in Northern blots by hy-
bridization with labeled  DNA.
Construction of cDNA library and cDNA isolation
Poly(A) mRNA prepared from sodium butyrate in-
duced BC-1 cells (4 h postinduction) was used in cDNA
synthesis using oligo(dT) primer and the Universal Ribo-
clone cDNA system (Promega). The double-stranded cD-
NAs were ligated to EcoRI adapters and inserted into
ZAP-2 vector (Stratagene, La Jolla, CA). The ligation
mixtures were packaged by using a Gigapack Gold
packaging extract and used to infect Escherichia coli
(XL1-Blue MRF strain) according to the manufacturer’s
instruction (Stratagene). 106 plaques were screened by
nucleic acid hybridization with radiolabeled-specific
cDNA probes. Positive phages were picked and purified
by two more subsequent steps of screening. Individual
ZAP-2 phages in positive clones were coinfected E. coli
cells (SOLR strain) with ExAssist helper phage where the
ZAP-2 phages were converted into plasmids (pBlue-
script SK). The cDNAs inserts were then analyzed by
sequencing.
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Rapid amplification of cDNA ends
A RACE-ready cDNA pool was generated using the
Marathon cDNA amplification kit with Advantage cDNA
polymerase mix (Clontech, Palo Alto, CA). Poly(A) RNA
was isolated from BC-1 cells that had been treated with
sodium butyrate for 4 h. Double-stranded cDNA pool was
synthesized with AMV reverse transcriptase and cDNA
synthesis primer (a modified lock-docking oligo(dT)
primer, Clontech). The cDNAs were ligated with Mara-
thon cDNA adapter (Clontech).
To obtain the 5 RACE fragment of 2.6-kb transcript, the
RACE-ready cDNA pool was amplified first with T2.6-
RACE1 (5 TCCAAGGCACTTCTGAACCTGCTGGGC 3,
50,022–50,048) and adaptor primer (AP1, provided in the
Marathon cDNA kit). The PCR products were then am-
plified with T2.6-RACE2 (5 CACCAAGGAGAACCTG-
GCGTCTTGCAAAGTTGA 3, 70,883–70,915) and nested
adaptor primer (AP2) from the kit. Similarly, the 5 portion
of K8 mRNA was obtained through two PCR reactions,
where K8C (5 TCAACATGGTGGGAGTGGCGCGTCC 3,
75,791–75,767) and AP1 were used in the first reaction
and K8-RACE 1 (5 TCTGCATTCAGTGAGCATGGCA-
GATGT 3, 75,136–75,110) and AP2 used in the second.
DNA fragments obtained in the RACE reactions were
cloned into T/A-type PCR cloning vectors, pCR2.1 (Invitro-
gen, Carlsbad, CA) and sequenced.
Nucleotide sequence accession number
The cDNA sequences of ORF48/29b and T3.0 have
been deposited in GenBank and were assigned the Ac-
cession Nos. AF402654 and AF402655.
ACKNOWLEDGMENT
This work was supported by a research grant to Y.Y. from the National
Institutes of Health (CA86839).
REFERENCES
Ambroziak, J. A., Blackbourn, D. J., Herndier, B. G., Glogau, R. G., Gullett,
J. H., McDonald, A. R., Lennette, E. T., and Levy, J. A. (1995). Herpes-
like sequences in HIV-infected and uninfected Kaposi’s sarcoma
patients. Science 268, 582–583.
Baines, J. D., Poon, A. P., Rovnak, J., and Roizman, B. (1994). The herpes
simplex virus 1 UL15 gene encodes two proteins and is required for
cleavage of genomic viral DNA. J. Virol. 68, 8118–8124.
Baines, J. D., Cunningham, C., Nalwanga, D., and Davison, A. (. (1997).
The UL15 gene of herpes simplex virus type 1 contains within its
second exon a novel open reading frame that is translated in frame
with the UL15 gene product. J. Virol. 71, 2666–2673.
Borja, A. Z. M., Merjers, C., and Zeller, R. (1993). Expression of alterna-
tively spliced bFGF first coding exons and antisense mRNAs during
chicken embryogenesis. Dev. Biol. 157, 110–118.
Burysek, L., and Pitha, P, M. (2001). Latently expressed human herpes-
virus 8-encoded interferon regulatory factor 2 inhibits double-
stranded RNA-activated protein kinase. J. Virol. 75, 2345–2352.
Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., and Knowles, D. M.
(1995). Kaposi’s sarcoma-associated herpesvirus-like DNA se-
quences in AIDS-related body-cavity-based lymphomas. N. Engl.
J. Med. 332, 1186–1191.
Cesarman, E., Moore, S., Rao, P. H., Inghirami, G., Knowles, D. M., and
Y. Chang, Y. (1995). In vitro establishment and characterization of two
acquired immunodeficiency syndrome-related lymphoma cell lines
(BC-1 and BC-2) containing Kaposi’s sarcoma-associated herpesvi-
rus-like (KSHV) DNA sequences. Blood 86, 2708–2714.
Chandran, B., Bloomer, C., Chan, S. R., Zhu, L., Goldstein, E., and
Horvat, R. (1998). Human herpesvirus-8 ORF K8.1 gene encodes
immunogenic glycoproteins generated by spliced transcripts. Virol-
ogy 249, 140–149.
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles,
D. M., and Moore, P. S. (1994). Identification of herpesvirus-like DNA
sequences in AIDS-associated Kaposi’s sarcoma. Science 266,
1865–1869.
Dittmer, D., Lagunoff, M., Renne, R., Staskus, K., Haase, A., and Ganem,
D. (1998). A cluster of latently expressed genes in Kaposi’s sarcoma-
associated herpesvirus. J. Virol. 72, 8309–8315.
Fixman, E. D., Hayward, G. S., and Hayward, S. D. (1995). Replication of
Epstein-Barr virus oriLyt: Lack of a dedicated virally encoded origin-
binding protein and dependence on Zta in cotransfection assays.
J. Virol. 69, 2998–3006.
Flore, O., Rafii, S., Ely, S., O’Leary, J. J., Hyjek, E. M., and Cesarman, E.
(1998). Transformation of primary human endothelial cells by Kapo-
si’s sarcoma-associated herpesvirus. Nature 394, 588–592.
Kedes D. H., Lagunoff, M., Renne, R., and Ganem, D. (1997). Identifica-
tion of the gene encoding the major latency-associated nuclear
antigen of the Kaposi’s sarcoma-associated herpesvirus. J. Clin.
Invest. 100, 2606–2610.
Kimelman, D., and Kirschner, M. W. (1989). An antisense mRNA directs
the covalent modification of the transcript encoding fibroblast growth
factor in Xenopus oocytes. Cell 59, 687–696.
Knee, R. S., Pitch, S. E., and Murphy, P. R. (1994). Basic fibroblast growth
factor sense (FGF) and antisense (gfg) RNA transcripts are ex-
pressed in unfertilized human oocytes and in differentiated adult
tissues. Biochem. Biophys. Res. Commun. 205, 577–583.
Li, M., MacKey, J., Czajak, S. C., Desrosiers, R. C., Lackner, A. A., and
Jung, J. U. (1999). Identification and characterization of Kaposi’s
sarcoma-associated herpesvirus K8.1 virion glycoprotein. J. Virol. 73,
1341–1349.
Lin, C. L., and Yuan, Y. (2002). Replication of Kaposi’s sarcoma-associ-
ated herpesvirus ori-Lyti K8 bzip protein binds to the origin. in press.
Lin, S.-F., Robinson, D. R., Miller, G., and Kung, H-J. (1999). Kaposi’s
sarcoma-associated herpesvirus encodes a bZIP protein with homol-
ogy to BZLF1 of Epstein-Barr virus. J. Virol. 73, 1909–1917.
Lukac, D. M., Kirshner, J. R., and Ganem, D. (1999). Transcriptional
activation by the product of open reading frame 50 of Kaposi’s
sarcoma-associated herpesvirus is required for lytic viral reactiva-
tion in B cells. J. Virol. 73, 9348–9361.
Lukac, D. M., Renne, R., Kirshner, J. R., and Ganem, D. (1998). Reacti-
vation of Kaposi’s sarcoma-associated herpesvirus infection from
latency by expression of the ORF 50 transactivator, a homolog of the
EBV R protein. Virology 252, 304–312.
Martin, D. F., Kuppermann, B. D., Wolitz, R. A., Palestine, A. G., Li, H., and
Robinson, C. A. (1999). Oral ganciclovir for patients with cytomega-
lovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir
Study Group. N. Engl. J. Med. 340, 1063–1070.
Miller, G. (1990). The switch between latency and replication of Epstein-
Barr virus. J. Infect. Dis. 161, 833–844.
Miller, G., Heston, L., Grogan, E., Gradoville, L., Rigsby, M., Sun, R.,
Shedd, D., Kushnaryov, V. M., Grossberg, S., and Chang, Y. (1997).
Selective switch between latency and lytic replication of Kaposi’s
sarcoma herpesvirus and Epstein-Barr virus in dually infected body
cavity lymphoma cells. J. Virol. 71, 314–324.
Moore, P. S., Gao, S. J., Dominguez, G., Cesarman, E., Lungu, O.,
Knowles, D. M., Garber, R., Pellett, P. E., McGeoch, D. J., and Chang,
313IMMEDIATE-EARLY TRANSCRIPTS OF KSHV
Y. (1996a). Primary characterization of a herpesvirus agent associ-
ated with Kaposi’s sarcoma. J. Virol. 70, 549–558.
Moore, P. S., Kingsley, L. A., Holmberg, S. D., Spira, T., Gupta, P., Hoover,
D. R., Parry, J. P., Conley, L. J., Jaffe, H. W., and Chang, Y. (1996b).
Kaposi’s sarcoma-associated herpesvirus infection prior to onset of
Kaposi’s sarcoma. AIDS 10, 175–180.
Morfeldt, L., and Torssander, J. (1994). Long-term remission of Kaposi’s
sarcoma following foscarnet treatment in HIV-infected patients.
Scand. J. Infect. Dis. 26, 749–752.
Muralidhar, S., Pumfery, A. M., Hassani, M., Sadaie, M. R., Azumi,
Kishishita, M., Brady, J. N., Doniger, J., Medveczky, P., and Rosenthal,
L. J. (1998). Identification of kaposin (open reading frame K12) as a
human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus)
transforming gene. J. Virol. 72, 4980–4988.
Raab, M. S., Albrecht, J. C., Birkmann, A., Yaguboglu, S., Lang, D.,
Fleckenstein, B., and Neipel, F. (1998). The immunogenic glycopro-
tein gp35–37 of human herpesvirus 8 is encoded by open reading
frame K8.1. J. Virol. 72, 6725–6731.
Rainbow, L., Platt, G. M., Simpson, G. R., Sarid, R., Gao, S.-J., Stoiber, H.,
Herrington, S., Moore, P. S., and Schulz, T. F. (1997). The 226- to
234-kilodalton latent nuclear antigen (LNA) of Kaposi’s sarcoma-
associated herpesvirus (human herpesvirus 8) is encoded by orf73
and is a component of the latency-associated nuclear antigen. J. Vi-
rol. 71, 5915–5921.
Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D.,
and Ganem, D. (1996). Lytic growth of Kaposi’s sarcoma-associated
herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2, 342–346.
Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena,
D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., and Moore, P. S.
(1996). Nucleotide sequence of the Kaposi’s sarcoma-associated
herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 91, 14862–14867.
Sadler, R., Wu, L., Forghani, B., Renne, R., Zhong, W., Herndier, B., and
Ganem, D. (1999). A complex translational program generates mul-
tiple novel proteins from the latently expressed kaposin (K12) locus
of Kaposi’s sarcoma-associated herpesvirus. J. Virol. 73, 5722–5730.
Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D.,
Babinet, P., d’Agay, M. F., Clauvel, J. P., Raphael, M., Degos, L., and
Sigaux, F. (1995). Kaposi’s sarcoma-associated herpesvirus-like DNA
sequences in multicentric Castleman’s disease. Blood 86, 1276–
1280.
Spivack, J. G., and Fraser, N. W. (1987). Detection of herpes simplex type
1 transcripts during latent infection in mice. J. Virol. 61,3841–3847.
Stevens, J. G., Wagner, E. K., Devi-Rao, G. B., Cook M. L., and Feldman,
L. T. (1987). RNA complementary to a herpes virus gene mRNA is
prominent in latently infected neurons. Science 235, 1056–1059.
Sun, R., Lin, S.-F., Gradoville, L., Zhu, F. X., Yuan, Y., and Miller, G. (1998).
A viral gene that activates lytic cycle expression of Kaposi’s sarcoma
associated herpesvirus. Proc. Natl. Acad. Sci. USA 95, 10866–10871.
Whitby, D., Howard, M. R., Tenant-Flowers, M., Brink, N. S., Copas, A.,
Boshoff, C., Hatzioannou, T., Suggett, F. E., Aldam, D. M., Denton,
A. S., et al. (1995). Detection of Kaposi sarcoma associated herpes-
virus in peripheral blood of HIV-infected individuals and progression
to Kaposi’s sarcoma. Lancet 346, 799–802.
Wu, F. Y., Ahn, J., Alcendor, D. J., Jang, W., Xiao, J., Hayward, S. D., and
Hayward, G. S. (2001). Origin-independent assembly of Kaposi’s
sarcoma-associated herpesvirus DNA replication compartments in
transient cotransfection assays and association with the ORF-K8
protein and cellular PML. J. Virol. 75, 1487–1506.
Yu, D., Sheaffer, A. K., Tenney, D. J., and Weller, S. K. (1997). Character-
ization of ICP6::lacZ insertion mutants of the UL15 gene of herpes
simplex virus type 1 reveals the translation of two proteins. J. Virol. 71,
2656–2665.
Yu, D., and Weller, S. K. (1998). Genetic analysis of the UL15 gene locus
for the putative terminase of herpes simplex virus type 1. Virology
243, 32–44.
Zhu, F. X., Cusano, T., and Yuan, Y. (1999). Identification of the immediate
early transcripts of Kaposi’s sarcoma-associated herpesvirus. J. Virol.
73, 5556–5567.
Zhu, F. X., King, S. M., Smith, E., Levy, D., and Yuan, Y. (2002). KSHV
immediate-early protein ORF45 inhibits virus-mediated induction of
type I interferon by blocking IRF-7 phosphorylation and nuclear
accumulation. Proc. Natl. Acad. Sci. USA 99, 5573–5578.
314 SAVELIEV, ZHU, AND YUAN
